Word: biotech
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...That's what happened to Gunjan Thiagarajah, 29, a sales and marketing employee at a biotech firm in Los Angeles, who graces this week's cover about India Inc. Last year Thiagarajah was a student in business school at UCLA when a friend invited her to a photo shoot with a stock photographer. She thought it would be a fun experience and a quick way to make $100. She had no idea that, through the process of stock photography, her face would become an international symbol for the future of India...
...what if you can't wait until the science is settled? Well, you could always turn to one of the start-up biotech firms that are providing limited genetic testing for about $250. "We have 19 genes we've identified that have a clear and defined response to diet and environmental or lifestyle choices," says Rosalynn Gill-Garrison, a molecular biologist who helped found the Sciona company in 2000. Worried about that caffeine-calcium link? Sciona tests for that, as well as genetic variants that affect insulin sensitivity, cholesterol levels and more...
...intervention that will slow the disease,” Brown said. “Obviously the real hope is a cure. Whether that is possible, I don’t know.”This summer, Kremer will be working on the launch of Avi Therapeutics, a for-profit biotech company that will try to commercialize academic research in the ALS field, according to Kremer. With these two companies, Kremer said he will continue to fight. “I want to save every ALS patient who lives today,” he said.LIVING AND LAUGHINGKremer has devoted the past...
...donations on their websites and given their boards oversight of the contributions. (Merck, which declined comment, began disclosing contributions last year, but its board doesn't supervise its giving.) Many companies fear alienating groups with competing political interests. Of 40 firms facing shareholder-sponsored disclosure resolutions, only one, the biotech firm Amgen, recommended a yes vote. Its measure passed last week...
...similar patents to target other drug makers with infringement claims. Signaling of the NF-kB molecule—the process at issue in Ariad’s dispute—is used by more than 200 compounds, including aspirin, according to Science magazine. Perhaps anticipating a future lawsuit, biotech company Amgen last week filed a pre-emptive motion asking a Delaware court to find Ariad’s patent invalid. The Thousand Oaks, Calif.-based firm also sought a ruling that its drug products do not infringe on the patent. Eli Lilly will contest the verdict by asking the judge...